+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Metabolism Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Metabolism Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Sulfonylurea Hypoglycemic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Sulfonylurea Hypoglycemic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • July 2025
  • 150 Pages
  • Global
From
Linagliptin DPP-4 Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Linagliptin DPP-4 Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Liraglutide and Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis by Application, End User, Distribution Channel, Dosage Form - Product Thumbnail Image

Liraglutide and Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis by Application, End User, Distribution Channel, Dosage Form

  • Report
  • January 2026
  • 160 Pages
  • Global
From
Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • November 2025
  • 160 Pages
  • Global
From
Antidiabetics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Antidiabetics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • November 2025
  • 160 Pages
  • Global
From
Metabolic Dysfunction-Associated Steatohepatitis (MASH): Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Metabolic Dysfunction-Associated Steatohepatitis (MASH): Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • June 2025
  • 131 Pages
  • Global
From
SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 87 Pages
  • Global
From
Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2025
  • 142 Pages
  • Global
From
DPP-4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

DPP-4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2025
  • 98 Pages
  • Global
From
Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Thumbnail Image

Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • March 2026
  • 135 Pages
  • Global
From
Diabetes Drug Market Overview, 2025-30 - Product Thumbnail Image

Diabetes Drug Market Overview, 2025-30

  • Report
  • June 2025
  • 109 Pages
  • Global
From
Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 198 Pages
  • Global
From
U.S. Hormone Therapy (Retail Side) Market Size, Share & Trends Analysis Report by Product (Sex Hormones, Thyroid Hormones), by Indication, by Route of Administration (Oral, Parenteral), by Distribution Channel, and Segment Forecasts, 2025-2033 - Product Thumbnail Image

U.S. Hormone Therapy (Retail Side) Market Size, Share & Trends Analysis Report by Product (Sex Hormones, Thyroid Hormones), by Indication, by Route of Administration (Oral, Parenteral), by Distribution Channel, and Segment Forecasts, 2025-2033

  • Report
  • August 2025
  • 100 Pages
  • United States
From
United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033 - Product Thumbnail Image

United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033

  • Report
  • August 2025
  • 200 Pages
  • United States
From
United States Diabetes Market Size, Share, Trends and Forecast by Segment, 2026-2034 - Product Thumbnail Image

United States Diabetes Market Size, Share, Trends and Forecast by Segment, 2026-2034

  • Report
  • February 2026
  • 150 Pages
  • United States
From
GCC Glp 1 Agonists Weight Loss Drugs Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Thumbnail Image

GCC Glp 1 Agonists Weight Loss Drugs Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • October 2025
  • 86 Pages
  • Middle East
From
Middle East and Africa Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 81 Pages
  • Middle East, Africa
From
Asia-Pacific Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 97 Pages
  • Asia Pacific
From
Europe Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Europe Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 100 Pages
  • Europe
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more